I/VC  Life Sciences Greenhouse

https://www.lsgpa.com/





     Office Locations:

3211 N. Front St., Suite #201
Harrisburg, PA 17110
Phone: 717-929-8729
Fax: 717-635-2010

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    The Life Sciences Greenhouse became operational in 2002 and is a public/private venture whose mission is to commercialize bioscience technologies. Clients include university-based researchers and technology development groups, emerging companies, and companies seeking to expand or relocate. The Life Sciences Greenhouse of Central Pennsylvania provides investment funding up to $2 million in milestone-driven convertible debt (which can be exchanged for a specified amount of another, related security, at the option of the issuer and/or the holder) or equity financing to viable seed-stage company (that is established with a CEO, a business plan and intellectual property assigned to it or owned by it, but typically no sales record as yet), or established life sciences companies that have significant potential for commercial growth.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Michele Washko President & CEO
    Ron Thiboutot PhD Board

     

    Portfolio companies include:


      Avisi Technologies


      Azevan


      Benten BioServices
        web link


      Chromatan


      Forma Medical


      Immunomic Therapeutics


      Indigo Biosciences


      MacuLogix
        web link


      Micro Interventional Devices


      Novasentis


      Quantum Bio


     

    Recent News: